Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Allogeneic Hematopoietic Stem Cell Transplant Recipient: early-phase trial registry
1 of 4 indexed Allogeneic Hematopoietic Stem Cell Transplant Recipient trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Allogeneic Hematopoietic Stem Cell Transplant Recipient: 4 US clinical trials tracked, 1 recruiting.
Allogeneic Hematopoietic Stem Cell Transplant Recipient is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is City of Hope Medical Center, running 2 of these trials.
Enrollment posture brief
Registry condition allogeneic-hematopoietic-stem-cell-transplant-recipient
OPEN 1 | RECR 25% | LATE 1 | EARLY 2 | RANK #4115 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Allogeneic Hematopoietic Stem Cell Transplant Recipient lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Allogeneic Hematopoietic Stem Cell Transplant Recipient on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Allogeneic Hematopoietic Stem Cell Transplant Recipient is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
City of Hope Medical Center
NCT04177004
Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplant
City of Hope Medical Center
NCT04160390
Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
M.D. Anderson Cancer Center
NCT03023631
Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant
National Cancer Institute (NCI)
NCT01822509
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Allogeneic Hematopoietic Stem Cell Transplant Recipient records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Allogeneic Hematopoietic Stem Cell Transplant Recipient trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Allogeneic Hematopoietic Stem Cell Transplant Recipient page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Allogeneic Hematopoietic Stem Cell Transplant Recipient trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- City of Hope Medical Center sponsors the most Allogeneic Hematopoietic Stem Cell Transplant Recipient trials on record, review their full trial history before evaluating a specific study. See City of Hope Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Allogeneic Hematopoietic Stem Cell Transplant Recipient condition card totals 4 registered trials; most-linked intervention Biospecimen Collection-Stool; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.